CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 40 enrolled
Drug / intervention
Harmonic ACE®+7 Shearsdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02278640
NCT02278640Phase 4Completed

Prospective, Multicenter, Study Evaluating Vessel Sealing Utilizing the Harmonic ACE®+7 Shears During Total Laparoscopic Hysterectomy

Ethicon Endo-Surgery·interventional·Posted Oct 30, 2014·Updated Aug 19, 2016

In Brief

A Phase 4 clinical trial evaluating Harmonic ACE®+7 Shears for Benign Disease Where Total Hysterectomy is Indicated. Completed, enrolled 40 participants across 4 sites in 3 countries.

Detailed Summary

This is a prospective, non-randomized, single arm, multicenter, study to assess the initial clinical experience with the Harmonic ACE®+7 Shears by evaluating vessel sealing during total laparoscopic hysterectomy. The study will not modify or influence current surgeon technique. Investigators will perform each procedure using the device in compliance with their standard surgical approach and product labeling. The Harmonic ACE®+7 Shears is cleared for commercial distribution and will be used in accordance with approved product labeling. The Harmonic ACE®+7 Shears will be assembled, calibrated, and/or used in accordance with manufacturer design specifications, product instructions and guidelines

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesNetherlands, United Kingdom, United States
Collaborators--

Timeline

Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
First PostedOct 30, 2014
Enrollment StartOct 1, 2014
Primary CompletionApr 1, 2015
Study CompletionJun 1, 2015
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 11.7 years ago

Interventions

Harmonic ACE®+7 Shearsdevice

Vessel/pedicle sealing performance assessed for transection and sealing of the of the uterine vasculature.